C74.11 — Malignant neoplasm of medulla of right adrenal gland
Is C74.11 billable?
Yes — C74.11 is billable for FY2027. C74.11 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C74.11 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C74.11 at a glance
| Code | C74.11 |
|---|---|
| Description | Malignant neoplasm of medulla of right adrenal gland |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C74.11 group to?
C74.11 sits in MDC 10 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 643Endocrine Disorders with MCCmedical
- 644Endocrine Disorders with CCmedical
- 645Endocrine Disorders without CC/MCCmedical
As a secondary diagnosis, C74.11 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.
How is C74.11 listed in the Alphabetic Index?
The Alphabetic Index lists these routes under C74.1, the nearest indexed parent of C74.11. Use them to find the family, then select the specific code.
- Paraganglioma › adrenal › malignant
How long has C74.11 existed?
C74.11 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.